445 related articles for article (PubMed ID: 15180354)
41. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
Valovirta E; Jacobsen L; Ljørring C; Koivikko A; Savolainen J
Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565
[TBL] [Abstract][Full Text] [Related]
42. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
Subiza J; Feliú A; Subiza JL; Uhlig J; Fernández-Caldas E
Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of immunotherapy by nasal antigen challenge.
Cengizlier R; Saraçlar Y; Tomaç N
J Otolaryngol; 1999 Aug; 28(4):185-8. PubMed ID: 10461254
[TBL] [Abstract][Full Text] [Related]
44. [Allergic rhinitis due to cockroach antigenic components. An emerging pathology?].
Liccardi G; Noschese P; Salzillo A; Morandi M; Calderaro F; D'Amato M; D'Amato G
Recenti Prog Med; 1996 May; 87(5):208-12. PubMed ID: 8767755
[TBL] [Abstract][Full Text] [Related]
45. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S; Ozcora E; Dirican A
ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):144-50. PubMed ID: 18391573
[TBL] [Abstract][Full Text] [Related]
46. [Quality of life in children with allergic rhinitis before and after being treated with specific immunotherapy (cases and controls)].
Moncayo Coello CV; Rosas Vargas MA; del Rio Navarro BE; Lerma Ortiz L; Velázquez Armenta Y; Sienra Monge JJ
Rev Alerg Mex; 2003; 50(5):170-5. PubMed ID: 14631587
[TBL] [Abstract][Full Text] [Related]
47. Issues in stinging insect allergy immunotherapy: a review.
Finegold I
Curr Opin Allergy Clin Immunol; 2008 Aug; 8(4):343-7. PubMed ID: 18596592
[TBL] [Abstract][Full Text] [Related]
48. Clinical experience with specific immunotherapy to horse dander.
Fernández-Távora L; Rico P; Martín S
J Investig Allergol Clin Immunol; 2002; 12(1):29-33. PubMed ID: 12109529
[TBL] [Abstract][Full Text] [Related]
49. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus.
Tabar AI; Echechipía S; García BE; Olaguibel JM; Lizaso MT; Gómez B; Aldunate MT; Martin S; Marcotegui F
J Allergy Clin Immunol; 2005 Jul; 116(1):109-18. PubMed ID: 15990782
[TBL] [Abstract][Full Text] [Related]
50. Monoid sublingual immunotherapy.
Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML
Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy.
Di Lorenzo G; Mansueto P; Pacor ML; Rizzo M; Castello F; Martinelli N; Ditta V; Lo Bianco C; Leto-Barone MS; D'Alcamo A; Di Fede G; Rini GB; Ditto AM
J Allergy Clin Immunol; 2009 May; 123(5):1103-10, 1110.e1-4. PubMed ID: 19356792
[TBL] [Abstract][Full Text] [Related]
52. Local immunotherapy in chronic allergic rhinitis and bronchial asthma with allergen aerosols. III. Dynamics of some sensitization and immunity indexes.
Moshkevich VS; Tsarevskaya LA; Nurpeisov TN; Nugmanova JS; Tsoy VP
Allergol Immunopathol (Madr); 1986; 14(4):277-85. PubMed ID: 3776777
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of oral immunotherapy in respiratory allergy to Parietaria judaica pollen. A double-blind study.
Ariano R; Panzani RC; Augeri G
J Investig Allergol Clin Immunol; 1998; 8(3):155-60. PubMed ID: 9684188
[TBL] [Abstract][Full Text] [Related]
54. [Immunotherapy in allergic diseases. Evaluation of short-term efficacy of aluminum hydroxide-absorbed slow-release preparations].
Spinozzi F; Cimignoli E; Broccucci L; Gerli R; Cernetti C; Rambotti P
Clin Ter; 1991 Feb; 136(4):245-51. PubMed ID: 1827386
[TBL] [Abstract][Full Text] [Related]
55. [Prevalence of reactions secundary to mosquito bites Aedes aegypti at en el Regional Center of Allergy and Clinical Immunology, University Hospital, de Monterrey, Nuevo Leon].
González Diaz SN; Cruz AA; Sedó Mejía GA; Rojas Lozano AA; Valenzuela EA; Vidaurri Ojeda AC
Rev Alerg Mex; 2010; 57(2):37-43. PubMed ID: 20857628
[TBL] [Abstract][Full Text] [Related]
56. [Safety analysis of dust mite allergen for diagnosis and immunotherapy of asthma and rhinitis].
Wen T; Cai Y; Chen X; Xiang L; Wang B; Zhuang Y
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(5):274-6. PubMed ID: 12563856
[TBL] [Abstract][Full Text] [Related]
57. [Immunotherapy against hymenoptera venom: report of ten patients].
Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
[TBL] [Abstract][Full Text] [Related]
58. [Allergen-specific immunotherapy].
Hansen TK; Svendsen UG
Ugeskr Laeger; 2005 Feb; 167(6):666-71. PubMed ID: 15771384
[No Abstract] [Full Text] [Related]
59. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
Colás C; Monzón S; Venturini M; Lezaun A
J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938
[TBL] [Abstract][Full Text] [Related]
60. Analysis of IgE-binding allergens in Culex quinquefasciatus saliva protein in mosquito bite allergic patients.
Wongkamchai S; Techasintana P; Wisuthsarewong W; Kulthanan K; Suthipinittharm P; Eakpo P
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):200-1. PubMed ID: 17304892
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
